EX-25.1 21 d237260dex251.htm STATEMENT OF ELIGIBILITY OF TRUSTEE, INDENTURE FOR 7.00% SENIOR NOTES DUE 2020 Statement of Eligibility of Trustee, Indenture for 7.00% Senior Notes due 2020

Exhibit 25.1

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM T-1

 

 

STATEMENT OF ELIGIBILITY

UNDER THE TRUST INDENTURE ACT OF 1939 OF A

CORPORATION DESIGNATED TO ACT AS TRUSTEE

 

 

CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b) (2)

 

 

WELLS FARGO BANK, NATIONAL ASSOCIATION

(Exact name of trustee as specified in its charter)

 

 

 

A National Banking Association   94-1347393

(Jurisdiction of incorporation or

organization if not a U.S. national bank)

 

(I.R.S. Employer

Identification No.)

101 North Phillips Avenue

Sioux Falls, South Dakota

  57104
(Address of principal executive offices)   (Zip code)

Wells Fargo & Company

Law Department, Trust Section

MAC N9305-175

Sixth Street and Marquette Avenue, 17th Floor

Minneapolis, Minnesota 55479

(612) 667-4608

(Name, address and telephone number of agent for service)

 

 

ENDO PHARMACEUTICALS HOLDINGS INC.

(Exact name of obligor as specified in its charter)

 

 

 

Delaware   13-4022871

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

TABLE OF GUARANTOR REGISTRANTS

 

Name of Guarantor Registrant*

   State or Other
Jurisdiction of
Incorporation
or Formation
   Primary
Standard
Industrial
Classification
Code Number
     I.R.S.
Employer
Identification
Number
 

Laserscope

   California      3845         77-0049527   

American Medical Systems Holdings, Inc.

   Delaware      5063         41-1978822   

American Medical Systems, Inc.

   Delaware      3842         13-4018241   

AMS Research Corporation

   Delaware      6719         13-3798523   

AMS Sales Corporation

   Delaware      5047         41-2018414   

Endo Pharmaceuticals Inc.

   Delaware      2834         52-2035829   

Endo Pharmaceuticals Solutions Inc.

   Delaware      2834         04-3047911   

Endo Pharmaceuticals Valera Inc.

   Delaware      2834         13-4119931   

Generics Bidco I, LLC

   Delaware      2834         26-1166905   

Generics Bidco II, LLC

   Delaware      2834         26-1166949   

Generics International (US), Inc.

   Delaware      2834         26-1166489   

Generics International (US Holdco), Inc.

   Delaware      2834         26-1166357   

Generics International (US Midco), Inc.

   Delaware      2834         26-1166302   

Generics International (US Parent), Inc.

   Delaware      2834         26-1166248   

Moores Mill Properties L.L.C.

   Delaware      2834         26-1309523   

Quartz Specialty Pharmaceuticals, LLC

   Delaware      2834         63-1255368   

Ledgemont Royalty Sub LLC

   Delaware      2834         30-0498695   

Vintage Pharmaceuticals, LLC

   Delaware      2834         63-1257882   

Wood Park Properties LLC

   Delaware      2834         N/A   

 

100 Endo Boulevard

Chadds Ford, Pennsylvania

  19317
(Address of principal executive offices)   (Zip code)

 

 

7.00% Senior Notes due 2020

(Title of the indenture securities)

 

 

 


Item 1. General Information. Furnish the following information as to the trustee:

 

  (a) Name and address of each examining or supervising authority to which it is subject.

 

    Comptroller of the Currency
    Treasury Department
    Washington, D.C.

 

    Federal Deposit Insurance Corporation
    Washington, D.C.

 

    Federal Reserve Bank of San Francisco
    San Francisco, California 94120

 

  (b) Whether it is authorized to exercise corporate trust powers.

 

    The trustee is authorized to exercise corporate trust powers.

Item 2. Affiliations with Obligor. If the obligor is an affiliate of the trustee, describe each such affiliation.

 

  None with respect to the trustee.

No responses are included for Items 3-14 of this Form T-1 because the obligor is not in default as provided under Item 13.

Item 15. Foreign Trustee. Not applicable.

Item 16. List of Exhibits. List below all exhibits filed as a part of this Statement of Eligibility.

 

Exhibit 1.    A copy of the Articles of Association of the trustee now in effect.*
Exhibit 2.    A copy of the Comptroller of the Currency Certificate of Corporate Existence and Fiduciary Powers for Wells Fargo Bank, National Association, dated February 4, 2004.**
Exhibit 3.    See Exhibit 2
Exhibit 4.    Copy of By-laws of the trustee as now in effect.***
Exhibit 5.    Not applicable.
Exhibit 6.    The consent of the trustee required by Section 321(b) of the Act.
Exhibit 7.    A copy of the latest report of condition of the trustee published pursuant to law or the requirements of its supervising or examining authority.
Exhibit 8.    Not applicable.
Exhibit 9.    Not applicable.


* Incorporated by reference to the exhibit of the same number to the trustee’s Form T-1 filed as exhibit 25 to the Form S-4 dated December 30, 2005 of Hornbeck Offshore Services LLC, file number 333-130784.
** Incorporated by reference to the exhibit of the same number to the trustee’s Form T-1 filed as exhibit T3G to the Form T-3 dated March 3, 2004 of Trans-Lux Corporation, file number 022-28721.
*** Incorporated by reference to the exhibit of the same number to the trustee’s Form T-1 filed as exhibit 25.1 to the Form S-4 dated May 26, 2005 of Penn National Gaming Inc., file number 333-125274.


SIGNATURE

Pursuant to the requirements of the Trust Indenture Act of 1939, as amended, the trustee, Wells Fargo Bank, National Association, a national banking association organized and existing under the laws of the United States of America, has duly caused this statement of eligibility to be signed on its behalf by the undersigned, thereunto duly authorized, all in the City of New York and State of New York on the 27th day of September, 2011.

 

WELLS FARGO BANK, NATIONAL ASSOCIATION

  /s/ Martin G. Reed

Martin G. Reed
Vice President


EXHIBIT 6

September 27, 2011

Securities and Exchange Commission

Washington, D.C. 20549

Gentlemen:

In accordance with Section 321(b) of the Trust Indenture Act of 1939, as amended, the undersigned hereby consents that reports of examination of the undersigned made by Federal, State, Territorial, or District authorities authorized to make such examination may be furnished by such authorities to the Securities and Exchange Commission upon its request therefor.

 

Very truly yours,
WELLS FARGO BANK, NATIONAL ASSOCIATION

  /s/ Martin G. Reed

Martin G. Reed
Vice President


Consolidated Report of Condition of

Wells Fargo Bank National Association

of 101 North Phillips Avenue, Sioux Falls, SD 57104

And Foreign and Domestic Subsidiaries,

at the close of business June 30, 2011, filed in accordance with 12 U.S.C. §161 for National Banks.

 

            Dollar Amounts
In Millions
 

ASSETS

     

Cash and balances due from depository institutions:

     

Noninterest-bearing balances and currency and coin

      $ 24,433   

Interest-bearing balances

        66,533   

Securities:

     

Held-to-maturity securities

        0   

Available-for-sale securities

        154,068   

Federal funds sold and securities purchased under agreements to resell:

     

Federal funds sold in domestic offices

        4,142   

Securities purchased under agreements to resell

        15,186   

Loans and lease financing receivables:

     

Loans and leases held for sale

        21,688   

Loans and leases, net of unearned income

     689,075      

LESS: Allowance for loan and lease losses

     17,922      

Loans and leases, net of unearned income and allowance

        671,153   

Trading Assets

        33,481   

Premises and fixed assets (including capitalized leases)

        8,103   

Other real estate owned

        4,705   

Investments in unconsolidated subsidiaries and associated companies

        566   

Direct and indirect investments in real estate ventures

        107   

Intangible assets

     

Goodwill

        20,936   

Other intangible assets

        25,816   

Other assets

        53,916   
     

 

 

 

Total assets

      $ 1,104,833   
     

 

 

 

LIABILITIES

     

Deposits:

     

In domestic offices

      $ 761,154   

Noninterest-bearing

     181,676      

Interest-bearing

     579,478      

In foreign offices, Edge and Agreement subsidiaries, and IBFs

        93,814   

Noninterest-bearing

     1,901      

Interest-bearing

     91,913      

Federal funds purchased and securities sold under agreements to repurchase:

     

Federal funds purchased in domestic offices

        3,170   

Securities sold under agreements to repurchase

        13,304   


     Dollar Amounts
In Millions
 

Trading liabilities

     20,222   

Other borrowed money

  

(includes mortgage indebtedness and obligations under capitalized leases)

     39,048   

Subordinated notes and debentures

     17,392   

Other liabilities

     31,532   
  

 

 

 

Total liabilities

   $ 979,636   

EQUITY CAPITAL

  

Perpetual preferred stock and related surplus

     0   

Common stock

     519   

Surplus (exclude all surplus related to preferred stock)

     99,145   

Retained earnings

     18,601   

Accumulated other comprehensive income

     5,614   

Other equity capital components

     0   
  

 

 

 

Total bank equity capital

     123,879   

Noncontrolling (minority) interests in consolidated subsidiaries

     1,318   
  

 

 

 

Total equity capital

     125,197   
  

 

 

 

Total liabilities, and equity capital

   $ 1,104,833   
  

 

 

 

I, Timothy J. Sloan, EVP & CFO of the above-named bank do hereby declare that this Report of Condition has been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and is true to the best of my knowledge and belief.

Timothy J. Sloan

EVP & CFO      

We, the undersigned directors, attest to the correctness of this Report of Condition and declare that it has been examined by us and to the best of our knowledge and belief has been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and is true and correct.

 

John Stumpf    Directors
Carrie Tolstedt   
Michael Loughlin